Heterologous_JJ Expression_NN of_IN Epothilone_NP Biosynthetic_NP Genes_NPS in_IN Myxococcus_NP xanthus_NP Epothilones_NP are_VBP potential_JJ anticancer_NN drugs_NNS that_WDT stabilize_VBP microtubules_NNS in_IN a_DT manner_NN similar_JJ to_TO paclitaxel_VB (_( Taxol_NP )_) ._SENT Epothilones_NNS are_VBP produced_VBN from_IN the_DT myxobacterium_NN Sorangium_NP cellulosum_NN ,_, which_WDT has_VBZ a_DT 16-h_NP doubling_NN time_NN and_CC produces_VBZ only_JJ milligram-per-liter_NN amounts_NNS of_IN epothilone_JJ A_NP and_CC epothilone_NP B._NP Furthermore_NP ,_, genetic_JJ manipulation_NN of_IN S._NP cellulosum_NN is_VBZ difficult_JJ ._SENT To_TO produce_VB epothilones_NNS in_IN a_DT more_RBR genetically_RB amenable_JJ and_CC rapidly_RB growing_VBG host_NN ,_, we_PP chose_VBD the_DT closely_RB related_JJ and_CC best-characterized_JJ myxobacteria_NN Myxococcus_NN xanthus_NN ._SENT We_PP inserted_VBD 65.4_CD kb_NN of_IN S._NP cellulosum_NN DNA_NN that_WDT encompassed_VBD the_DT entire_JJ epothilone_NN gene_NN cluster_NN into_IN the_DT chromosome_NN of_IN M._NP xanthus_NN by_IN a_DT series_NN of_IN homologous_JJ recombination_NN events_NNS ._SENT The_DT resulting_VBG strain_NN produced_VBD epothilones_NNS A_NP and_CC B._NP Construction_NP of_IN a_DT strain_NN that_WDT contained_VBD a_DT mutation_NN in_IN epoK_NN ,_, the_DT P450_NP epoxidase_NN ,_, resulted_VBN in_IN production_NN of_IN epothilones_NNS C_NP and_CC D._NP Epothilones_NP are_VBP potent_JJ cytotoxic_JJ macrocyclic_JJ lactones_NNS that_WDT show_VBP promise_NN as_IN anticancer_NN drugs_NNS ._SENT The_DT mechanism_NN of_IN action_NN is_VBZ similar_JJ to_TO the_DT anticancer_NN drug_NN paclitaxel_NN (_( Taxol_NP )_) ;_: both_DT bind_NN and_CC stabilize_VB microtubules_NNS ,_, which_WDT leads_VBZ to_TO cell_NN death_NN ._SENT Epothilones_NNS have_VBP superior_JJ features_NNS relative_JJ to_TO paclitaxel_NN ._SENT First_RB ,_, epothilones_NNS are_VBP more_JJR water_NN soluble_JJ ._SENT This_DT may_MD enable_VB a_DT formulation_NN without_IN the_DT use_NN of_IN the_DT solubilizing_VBG agent_NN cremophor_NN ,_, currently_RB used_VBN in_IN formulations_NNS of_IN paclitaxel_NN ._SENT Cremophor_NP ,_, on_IN its_PP$ own_JJ ,_, can_MD affect_VB cardiac_JJ function_NN and_CC cause_VB severe_JJ hypersensitivity_NN ._SENT Second_RB ,_, epothilones_NNS are_VBP effective_JJ against_IN tumors_NNS resistant_JJ to_TO paclitaxel_NN ._SENT These_DT advantages_NNS make_VBP epothilones_NNS likely_JJ successors_NNS to_TO paclitaxel_NN ._SENT The_DT need_NN for_IN sufficient_JJ material_NN is_VBZ a_DT major_JJ obstacle_NN to_TO the_DT development_NN of_IN epothilones_NNS as_IN marketable_JJ drugs_NNS ._SENT The_DT total_JJ synthesis_NN of_IN epothilone_NP A_NP and_CC epothilone_NP B_NP has_VBZ been_VBN accomplished_VBN ._SENT However_RB ,_, the_DT number_NN of_IN steps_NNS required_VBN for_IN synthesis_NN of_IN these_DT molecules_NNS precludes_VBZ this_DT as_IN an_DT economical_JJ method_NN of_IN production_NN ._SENT Fermentation_NN methods_NNS thus_RB remain_VBP the_DT favored_JJ route_NN of_IN production_NN ._SENT Epothilones_NNS are_VBP produced_VBN from_IN the_DT gram-negative_JJ myxobacterium_NN Sorangium_NP cellulosum_NN ._SENT The_DT reported_VBN yields_NNS of_IN epothilones_NNS from_IN S._NP cellulosum_NN strain_NN So_IN ce90_NN are_VBP approximately_RB 20_CD mg_NN of_IN epothilone_NN A_DT per_FW liter_NN and_CC 10_CD mg_NN of_IN epothilone_JJ B_NN per_IN liter_NN ._SENT A_DT disadvantage_NN of_IN S._NP cellulosum_NN is_VBZ the_DT relatively_RB long_JJ doubling_NN time_NN ,_, which_WDT is_VBZ approximately_RB 16_CD h_NN and_CC is_VBZ the_DT longest_JJS of_IN all_DT myxobacteria_NN ._SENT Furthermore_RB ,_, S._NP cellulosum_NN is_VBZ difficult_JJ to_TO engineer_VB ,_, due_JJ to_TO the_DT low_JJ efficiency_NN of_IN introducing_VBG DNA_NN into_IN the_DT bacterium_NN and_CC the_DT limited_JJ number_NN of_IN molecular_JJ tools_NNS and_CC markers_NNS that_WDT have_VBP been_VBN developed_VBN ._SENT Recently_RB ,_, the_DT epothilone_JJ biosynthetic_JJ gene_NN cluster_NN was_VBD sequenced_JJ ,_, and_CC the_DT genes_NNS were_VBD introduced_VBN into_IN Streptomyces_NP coelicolor_NN ,_, a_DT common_JJ host_NN used_VBN for_IN production_NN of_IN a_DT variety_NN of_IN polyketides_NNS from_IN actinomycetes_NNS ._SENT The_DT heterologous_JJ strain_NN produced_VBD small_JJ quantities_NNS of_IN epothilones_NNS ;_: production_NN of_IN epothilones_NNS in_IN S._NP coelicolor_NN may_MD have_VB a_DT cytotoxic_JJ effect_NN (_( L._NP Tang_NP et_FW al._FW ,_, unpublished_JJ data_NNS )_) ._SENT Thus_RB ,_, an_DT alternative_JJ heterologous_JJ host_NN is_VBZ desired_VBN ._SENT We_PP speculated_VBD that_IN a_DT superior_JJ expression_NN host_NN for_IN epothilones_NNS might_MD be_VB another_DT myxobacterium_NN and_CC chose_VBD Myxococcus_NP xanthus_NN for_IN several_JJ reasons_NNS ._SENT First_RB ,_, M._NP xanthus_NP is_VBZ the_DT best-characterized_JJ myxobacterium_NN and_CC is_VBZ readily_RB amenable_JJ to_TO engineering_NN ._SENT Second_RB ,_, M._NP xanthus_NP has_VBZ a_DT significantly_RB shorter_JJR doubling_NN time_NN than_IN S._NP cellulosum_NN (_( 5_CD versus_IN 16_CD h_NN )_) ,_, which_WDT would_MD in_RB itself_PP enhance_VB volumetric_JJ productivity_NN ._SENT Third_JJ ,_, expression_NN of_IN the_DT epothilone_JJ genes_NNS in_IN M._NP xanthus_NN may_MD not_RB require_VB the_DT engineering_NN of_IN new_JJ promoters_NNS ,_, because_IN M._NP xanthus_NP and_CC S._NP cellulosum_NN are_VBP closely_RB related_VBN organisms_NNS ._SENT The_DT epothilones_NNS are_VBP polyketides_NNS that_WDT are_VBP synthesized_VBN by_IN a_DT type_NN I_PP polyketide_VBP synthase_NN ._SENT These_DT enzymes_NNS are_VBP large_JJ multifunctional_JJ complexes_NNS organized_VBN in_IN a_DT modular_JJ fashion_NN and_CC catalyze_VB the_DT successive_JJ condensation_NN of_IN carboxylic_JJ acid_JJ residues_NNS from_IN their_PP$ coenzyme_NN A_DT (_( CoA_NP )_) esters_NNS ,_, typically_RB malonyl-CoA_NN and_CC methylmalonyl-CoA_NN ._SENT Polyketide_NN synthase_NN enzymes_NNS are_VBP synthesized_VBN as_IN an_DT apo_NN form_NN and_CC are_VBP converted_VBN to_TO the_DT holo_NN form_NN by_IN the_DT addition_NN of_IN a_DT phosphopantetheinyl_NN (_( P-pant_NP )_) moiety_NN to_TO a_DT serine_NN residue_NN of_IN the_DT acyl_NN or_CC peptidyl_NN carrier_NN protein_NN (_( ACP_NN or_CC PCP_NP )_) domains_NNS by_IN an_DT enzyme_NN called_VBD P-pant_JJ transferase_NN ._SENT Thus_RB ,_, a_DT heterologous_JJ host_NN must_MD synthesize_VB malonyl-CoA_NN and_CC methylmalonyl-CoA_NN as_IN well_RB as_RB harbor_VB a_DT P-pant_JJ transferase_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Genetic_JJ map_NN of_IN the_DT epothilone_JJ biosynthetic_JJ gene_NN cluster_NN ._SENT Genetic_JJ map_NN of_IN the_DT epothilone_JJ biosynthetic_JJ gene_NN cluster_NN ._SENT The_DT boxes_NNS represent_VBP genes_NNS ,_, and_CC the_DT modules_NNS encoded_VBN by_IN each_DT are_VBP designated_VBN below_RB ._SENT The_DT long_JJ arrow_NN represents_VBZ the_DT direction_NN of_IN transcription_NN ._SENT Before_IN initiating_VBG this_DT work_NN ,_, it_PP was_VBD unknown_JJ whether_IN M._NP xanthus_NP contains_VBZ a_DT P-pant_JJ transferase_NN or_CC methylmalonyl-CoA_NN ._SENT It_PP is_VBZ known_VBN that_IN strains_NNS of_IN M._NP xanthus_NNS produce_VBP the_DT polyketide_NN myxovirescins_NNS ,_, also_RB known_VBN as_IN TA_NP ._SENT Thus_RB ,_, it_PP is_VBZ likely_JJ to_TO contain_VB a_DT P-pant_JJ transferase_NN ,_, but_CC whether_IN it_PP would_MD function_VB on_IN the_DT ACP_NN and_CC PCP_NP domains_NNS of_IN the_DT epothilone_JJ polyketide_NN synthase_NN remained_VBD to_TO be_VB determined_VBN ._SENT Although_IN myxovirescins_NNS contains_VBZ methyl_NN groups_NNS extending_VBG from_IN the_DT ring_NN ,_, they_PP are_VBP all_RB derived_VBN from_IN S-adenosylmethionine_NP and_CC not_RB from_IN the_DT utilization_NN of_IN methylmalonyl-CoA_NN ._SENT Thus_RB ,_, evidence_NN for_IN the_DT production_NN of_IN methylmalonyl-CoA_NN cannot_MD be_VB deduced_VBN from_IN the_DT polyketides_NNS that_WDT are_VBP made_VBN naturally_RB from_IN this_DT host_NN ._SENT Work_VB studying_VBG the_DT developmental_JJ life_NN cycle_NN of_IN M._NP xanthus_NP has_VBZ revealed_VBN the_DT presence_NN of_IN the_DT genes_NNS for_IN propionyl-CoA_NN carboxylase_NN ,_, an_DT enzyme_NN used_VBN to_TO synthesize_VB methyl_NN malonyl-CoA_NN ._SENT Thus_RB ,_, M._NP xanthus_NP is_VBZ likely_JJ to_TO possess_VB required_VBN components_NNS to_TO synthesize_VB epothilone_NN ._SENT Because_IN of_IN the_DT advantages_NNS of_IN using_VBG M._NP xanthus_NN as_IN a_DT host_NN for_IN production_NN of_IN epothilone_NN ,_, we_PP introduced_VBD the_DT epothilone_JJ genes_NNS from_IN S._NP cellulosum_NN into_IN the_DT chromosome_NN of_IN M._NP xanthus_NN ._SENT We_PP demonstrate_VBP that_IN the_DT engineered_JJ strain_NN produces_VBZ epothilones_NNS ._SENT We_PP also_RB constructed_VBD mutations_NNS in_IN epoK_NN ,_, the_DT CYP450_NP ,_, which_WDT is_VBZ responsible_JJ for_IN the_DT formation_NN of_IN the_DT epoxide_NN at_IN C-12-C-13_NP ._SENT This_DT strain_NN produces_VBZ epothilone_NP C_NP and_CC epothilone_NP D._NP Bacterial_NP strains_NNS ._SENT |_SYM Escherichia_NP coli_NNS strains_NNS XL1-Blue_NP and_CC DH10B_NP were_VBD used_VBN for_IN transformations_NNS ._SENT M._NP xanthus_NP strain_NN DZ1_NP was_VBD the_DT recipient_NN for_IN the_DT epothilone_JJ genes_NNS ._SENT It_PP is_VBZ streptomycin_NN resistant_JJ and_CC is_VBZ a_DT nonmotile_JJ strain_NN that_WDT is_VBZ unable_JJ to_TO form_VB fruiting_VBG bodies_NNS Media_NN and_CC growth_NN conditions_NNS ._SENT |_SYM E._NP coli_NNS with_IN plasmids_NNS were_VBD grown_VBN in_IN Luria-Bertani_NP medium_NN containing_VBG 0.5_CD %_NN NaCl_NN at_IN 37C_JJ supplemented_VBN with_IN ampicillin_NN (_( 50_CD mug/ml_NN )_) ,_, kanamycin_NN (_( 50_CD mug/ml_NN )_) ,_, or_CC tetracycline_NN (_( 15_CD mug/ml_NN )_) ._SENT DZ1_NP was_VBD grown_VBN in_IN CYE_NP at_IN 30_CD or_CC 32C_JJ ._SENT For_IN selection_NN of_IN galactose_NN resistance_NN in_IN M._NP xanthus_NN ,_, cells_NNS were_VBD plated_VBN in_IN 2.5_CD ml_NN of_IN CYE_NP top_JJ agar_NN and_CC poured_VBN onto_IN CYE_NP plates_NNS containing_VBG 1_CD %_NN galactose_NN ._SENT The_DT following_VBG antibiotics_NNS were_VBD used_VBN for_IN M._NP xanthus_NN :_: kanamycin_NN (_( 50_CD mug/ml_NN )_) and_CC oxytetracycline_NN (_( 10_CD to_TO 15_CD mug/ml_NN )_) ._SENT To_TO test_VB for_IN the_DT production_NN of_IN epothilone_NN ,_, cells_NNS were_VBD cultured_VBN in_IN CMM_NP (_( 0.5_CD %_NN Casitone_NP ,_, 0.2_CD %_NN MgSO4_NP ,_, 10_CD mM_NP morpholinepropanesulfonic_JJ acid_NN [_SYM MOPS_NP ]_SYM [_SYM pH_NN 7.6_CD ]_SYM )_) supplemented_VBD with_IN the_DT following_VBG amino_NN acids_NNS (_( 1_CD mg/liter_NN )_) :_: serine_NN ,_, glycine_NN ,_, and_CC alanine_NN ._SENT The_DT cells_NNS were_VBD initially_RB grown_VBN in_IN CYE_NP medium_NN ,_, and_CC while_IN in_IN mid-log_NN phase_NN a_DT 5_CD %_NN inoculum_NN was_VBD used_VBN to_TO inoculate_VB a_DT flask_NN containing_VBG production_NN medium_NN ._SENT The_DT cultures_NNS were_VBD grown_VBN at_IN 30C_JJ for_IN 64_CD to_TO 72_CD h._NP XAD-16_NP is_VBZ an_DT absorber_NN resin_NN that_WDT was_VBD used_VBN in_IN production_NN cultures_NNS to_TO bind_VB the_DT epothilones_NNS ._SENT To_TO prepare_VB the_DT XAD-16_NP ,_, 2_CD %_NN was_VBD added_VBN to_TO a_DT fermentation_NN flask_NN ,_, covered_VBN with_IN water_NN ,_, and_CC autoclaved_VBN ._SENT Afterwards_RB ,_, the_DT water_NN was_VBD removed_VBN ,_, CMM_NP was_VBD added_VBN ,_, and_CC the_DT culture_NN was_VBD inoculated_VBN ._SENT Extraction_NN of_IN epothilones_NNS ._SENT |_SYM To_TO extract_VB epothilones_NNS from_IN cells_NNS and_CC from_IN the_DT culture_NN (_( cells_NNS and_CC medium_NN )_) ,_, an_DT equal_JJ volume_NN of_IN acetone_NN was_VBD added_VBN and_CC shaken_VBN at_IN room_NN temperature_NN for_IN an_DT hour_NN ._SENT The_DT acetone_NN mixture_NN was_VBD extracted_VBN twice_RB with_IN an_DT equal_JJ volume_NN of_IN ethyl_NN acetate_NN ,_, and_CC the_DT ethyl_NN acetate_NN fraction_NN was_VBD dried_VBN and_CC resuspended_VBN in_IN acetonitrile_NN ._SENT To_TO analyze_VB epothilones_NNS bound_VBN to_TO XAD-16_NP ,_, the_DT culture_NN broth_NN was_VBD removed_VBN and_CC the_DT resin_NN was_VBD washed_VBN twice_RB with_IN 5_CD volumes_NNS of_IN MilliQ_NP water_NN ._SENT The_DT epothilones_NNS were_VBD eluted_VBN with_IN methanol_NN and_CC analyzed_VBD by_IN liquid_JJ chromatography-mass_NN spectrometry_NN ._SENT DNA_NN methods_NNS ._SENT |_SYM Standard_NP DNA_NP protocols_NNS were_VBD used_VBN for_IN E._NP coli_NNS ._SENT The_DT isolation_NN of_IN M._NP xanthus_NP chromosomal_JJ DNA_NN was_VBD done_VBN as_IN previously_RB described_VBN ._SENT Electroporation_NN of_IN M._NP xanthus_NN was_VBD described_VBN by_IN Kashefi_NP and_CC Hartzell_NP Transposition_NP reactions_NNS ._SENT |_SYM The_DT tetracycline_NN resistance_NN gene_NN was_VBD added_VBN to_TO the_DT cosmids_NNS pKOS35-70.1A2_NN and_CC pKOS35-79.85_NN using_VBG the_DT in_IN vivo_JJ transposition_NN reaction_NN kit_NN from_IN Epicentre_NP Technologies_NPS ._SENT The_DT transposon_NN used_VBN was_VBD EZ::TN_NP <TET-1>_ ,_, and_CC the_DT reaction_NN was_VBD performed_VBN as_IN recommended_VBN by_IN the_DT manufacturer_NN ._SENT Resulting_VBG tetracycline-resistant_JJ colonies_NNS were_VBD screened_VBN for_IN resistance_NN to_TO kanamycin_NN ._SENT Those_DT colonies_NNS resistant_JJ to_TO tetracycline_NN and_CC sensitive_JJ to_TO kanamycin_NN were_VBD kept_VBN ,_, and_CC the_DT DNA_NN was_VBD digested_VBN with_IN restriction_NN enzymes_NNS to_TO verify_VB that_IN no_DT deletions_NNS had_VBD occurred_VBN ._SENT The_DT tetracycline_NN resistant_JJ versions_NNS of_IN pKOS35-70.1A2_NN and_CC pKOS35-79.85_NN are_VBP pKOS90-38_JJ and_CC pKOS90-23_JJ ,_, respectively_RB ._SENT Construction_NN of_IN pKOS35-154_NN and_CC pKOS90-22_NN ._SENT |_SYM Plasmids_NNS that_WDT contained_VBD regions_NNS of_IN the_DT epo_NN genes_NNS flanked_VBN by_IN M._NP xanthus_NP DNA_NP were_VBD constructed_VBN for_IN homologous_JJ recombination_NN of_IN the_DT epo_NN genes_NNS into_IN the_DT chromosome_NN ._SENT Plasmid_NP pKOS35-154_NP was_VBD constructed_VBN in_IN several_JJ steps_NNS ._SENT First_RB ,_, the_DT ca_MD ._SENT 3-kb_JJ BamHI-to-NdeI_NP fragment_NN from_IN KG2_NP was_VBD ligated_VBN into_IN the_DT BglII_NP and_CC NdeI_NP sites_NNS of_IN pSL1190_NN (_( Amersham-Pharmacia_NP )_) ._SENT This_DT plasmid_NP ,_, pKOS55-178_NN ,_, contains_VBZ the_DT kanamycin_NN resistance_NN and_CC galK_NN cassette_NN that_WDT is_VBZ used_VBN for_IN positive_JJ and_CC negative_JJ selection_NN in_IN M._NP xanthus_NN ._SENT Next_RB ,_, a_DT 4.7-kb_JJ NotI_NP fragment_NN from_IN cosmid_JJ pKOS35-79.85_NN ,_, containing_VBG a_DT portion_NN of_IN the_DT coding_VBG sequence_NN for_IN module_NN 7_CD ,_, was_VBD ligated_VBN into_IN the_DT NotI_NP site_NN of_IN pKOS55-178_NN to_TO create_VB pKOS55-183.b_NN ._SENT Plasmid_NP pKOS55-183.b_NP was_VBD cleaved_VBN with_IN MfeI_NP ,_, and_CC the_DT DNA_NP ends_NNS were_VBD made_VBN blunt_JJ with_IN the_DT Klenow_NP fragment_NN of_IN DNA_NN polymerase_NN I_PP and_CC ligated_VBD with_IN a_DT 5,088-bp_JJ SrfI_NP fragment_NN from_IN pKOS35-79.85_NN ._SENT This_DT plasmid_NN ,_, pKOS90-1_JJ ,_, contains_VBZ two_CD regions_NNS of_IN the_DT epo_NN gene_NN cluster_NN flanking_VBG the_DT kanamycin_NN resistance_NN and_CC galK_NN cassette_NN ._SENT To_TO add_VB flanking_VBG DNA_NN from_IN M._NP xanthus_NN to_TO recombine_VB the_DT epo_NN genes_NNS from_IN pKOS90-1_NN into_IN the_DT chromosome_NN ,_, plasmid_NP pKOS35-151_NP was_VBD constructed_VBN as_RB follows_VBZ ._SENT Plasmid_NP pBJ130_NP ,_, which_WDT carries_VBZ the_DT dev_NN locus_NN from_IN M._NP xanthus_NP ,_, was_VBD cleaved_VBN with_IN KpnI_NP ;_: the_DT DNA_NN ends_NNS were_VBD made_VBN blunt_JJ with_IN the_DT Klenow_NP fragment_NN of_IN DNA_NN polymerase_NN I_PP and_CC ligated_VBD with_IN the_DT polylinker_NN from_IN pSL1190_NN (_( Pharmacia_NP )_) ,_, which_WDT had_VBD been_VBN cleaved_VBN with_IN EcoRI_NP and_CC HindIII_NP ;_: and_CC the_DT DNA_NP ends_NNS were_VBD made_VBN blunt_JJ with_IN the_DT Klenow_NP fragment_NN ._SENT This_DT plasmid_NN ,_, pKOS35-151_JJ ,_, was_VBD cleaved_VBN with_IN SpeI_NP and_CC EcoRI_NP and_CC ligated_VBN with_IN the_DT 12-kb_JJ SpeI-EcoRI_NP fragment_NN from_IN pKOS90-1_NN to_TO create_VB pKOS35-154_NN ._SENT Plasmid_NP pKOS90-22_NN was_VBD used_VBN for_IN recombining_VBG the_DT 5_CD '_POS end_NN of_IN the_DT epo_NN gene_NN cluster_NN into_IN the_DT M._NP xanthus_NN chromosome_NN ._SENT First_RB ,_, a_DT portion_NN of_IN the_DT epo_NN genes_NNS encoded_VBN by_IN module_NN 6_CD and_CC module_NN 7_CD was_VBD isolated_VBN as_IN an_DT 8.8-kb_JJ BglII_NP fragment_NN from_IN cosmid_JJ pKOS35-70.4_NN and_CC ligated_VBN into_IN the_DT BamHI_NP site_NN of_IN pKOS55-178_NN to_TO create_VB pKOS90-12_NN ._SENT To_TO isolate_VB a_DT fragment_NN upstream_RB of_IN the_DT start_NN of_IN the_DT epo_NN genes_NNS ,_, a_DT 9.5-kb_NP NsiI-to-AvrII_NP fragment_NN from_IN cosmid_JJ pKOS35-70.8A3_NN was_VBD ligated_VBN into_IN the_DT PstI_NP and_CC AvrII_NP sites_NNS of_IN pSL1190_NN to_TO yield_VB pKOS90-13_NN ._SENT Next_JJ ,_, pKOS35-151_JJ was_VBD cleaved_VBN with_IN EcoRI_NP and_CC HindIII_NP ,_, the_DT DNA_NP ends_NNS were_VBD made_VBN blunt_JJ with_IN the_DT Klenow_NP fragment_NN ,_, and_CC the_DT plasmid_NN was_VBD religated_JJ ._SENT This_DT plasmid_NP ,_, pKOS90-5_NN ,_, was_VBD cleaved_VBN with_IN MfeI_NP and_CC AvrII_NP and_CC ligated_VBN with_IN the_DT 11.5-kb_JJ EcoRI-SpeI_NP fragment_NN from_IN pKOS90-12_NN to_TO construct_VB pKOS90-17_JJ ._SENT Finally_RB ,_, pKOS90-22_NN was_VBD constructed_VBN by_IN cleaving_VBG pKOS90-17_JJ with_IN SpeI_NP and_CC ligating_VBG it_PP with_IN the_DT 9.5-kb_JJ SpeI-AvrII_NP fragment_NN from_IN pKOS90-13_NN ._SENT Construction_NN of_IN an_DT epoK_NN mutant_NN ._SENT |_SYM To_TO construct_VB an_DT epoK_NN mutant_NN ,_, a_DT kanamycin_NN resistance_NN cassette_NN was_VBD inserted_VBN into_IN the_DT epoK_NN gene_NN ._SENT This_DT was_VBD done_VBN by_IN isolating_VBG the_DT 4,879-bp_JJ fragment_NN from_IN pKOS35-79.85_NN ,_, which_WDT contains_VBZ epoK_NNS ,_, and_CC ligating_VBG it_PP into_IN the_DT NotI_NP site_NN of_IN pBluescript_NN SKII(+_NP )_) ._SENT This_DT plasmid_NP ,_, pKOS35-83.5_NN ,_, was_VBD partially_RB cleaved_VBN with_IN ScaI_NP ,_, and_CC the_DT 7.4-kb_NP fragment_NN was_VBD ligated_VBN with_IN the_DT 1.5-kb_JJ EcoRI-BamHI_NP kanamycin_NN resistance_NN gene_NN from_IN pBJ180-2_NN (_( B._NP Julien_NP and_CC D._NP Kaiser_NP ,_, unpublished_JJ )_) ,_, which_WDT had_VBD the_DT DNA_NP ends_NNS made_VBD blunt_JJ with_IN the_DT Klenow_NP fragment_NN ,_, to_TO yield_VB plasmid_NN pKOS90-55_NN ._SENT Finally_RB ,_, the_DT ca_MD ._SENT 400-bp_JJ RP4_NP oriT_NN fragment_NN from_IN pBJ183_NN (_( Julien_NP and_CC Kaiser_NP ,_, unpublished_JJ )_) was_VBD ligated_VBN into_IN the_DT XbaI_NP and_CC EcoRI_NP sites_NNS to_TO create_VB pKOS90-63_NN ._SENT This_DT plasmid_NN was_VBD linearized_VBN with_IN DraI_NP and_CC electroporated_VBN into_IN the_DT M._NP xanthus_NN strain_NN K111-32.25_NP to_TO create_VB K111-40_NP ._SENT To_TO create_VB a_DT markerless_JJ epoK_NN mutation_NN ,_, pKOS35-83.5_NN was_VBD cleaved_VBN with_IN ScaI_NP ,_, and_CC the_DT 2.9-_CD and_CC 4.3-kb_JJ fragments_NNS were_VBD ligated_VBN together_RB ._SENT This_DT plasmid_NN ,_, pKOS90-101_JJ ,_, has_VBZ an_DT in-frame_JJ deletion_NN in_IN epoK_NN ._SENT Next_RB ,_, the_DT 3-kb_JJ BamHI-NdeI_NP fragment_NN from_IN KG2_NP ,_, which_WDT had_VBD the_DT DNA_NP ends_NNS made_VBD blunt_JJ with_IN the_DT Klenow_NP fragment_NN and_CC contains_VBZ the_DT kanamycin_NN resistance_NN and_CC galK_NN genes_NNS ,_, was_VBD ligated_VBN into_IN the_DT DraI_NP site_NN of_IN pKOS90-101_NN to_TO create_VB pKOS90-105_NN ._SENT This_DT plasmid_NN was_VBD electroporated_VBN into_IN K111-32_NP ,_, and_CC kanamycin-resistant_NN colonies_NNS were_VBD selected_VBN ._SENT To_TO replace_VB the_DT wild-type_NN copy_NN of_IN epoK_NNS with_IN the_DT deletion_NN ,_, the_DT second_JJ recombination_NN event_NN was_VBD selected_VBN by_IN growth_NN on_IN galactose_NN plates_NNS ._SENT These_DT galactose-resistant_JJ colonies_NNS were_VBD screened_VBN for_IN production_NN of_IN epothilone_NP C_NP and_CC D._NP This_DT strain_NN is_VBZ designated_VBN K111-72_NP ._SENT Construction_NN of_IN an_DT M._NP xanthus_NN strain_NN containing_VBG the_DT epothilone_JJ gene_NN cluster_NN ._SENT |_SYM To_TO reconstruct_VB the_DT epothilone_JJ gene_NN cluster_NN in_IN M._NP xanthus_NN ,_, we_PP chose_VBD to_TO introduce_VB the_DT cluster_NN into_IN the_DT chromosome_NN by_IN homologous_JJ recombination_NN ._SENT This_DT entails_NNS placing_VBG regions_NNS of_IN homology_NN from_IN the_DT epothilone_JJ genes_NNS into_IN the_DT chromosome_NN of_IN M._NP xanthus_NN and_CC using_VBG these_DT regions_NNS as_IN recombination_NN sites_NNS for_IN cosmids_NNS containing_VBG parts_NNS of_IN the_DT epo_NN gene_NN cluster_NN ._SENT The_DT location_NN on_IN the_DT M._NP xanthus_NN chromosome_NN chosen_VBN for_IN the_DT recombination_NN site_NN was_VBD 3_CD '_'' of_IN the_DT dev_NP operon_NN ._SENT This_DT region_NN encodes_VBZ no_DT recognizable_JJ genes_NNS ,_, and_CC insertions_NNS in_IN this_DT region_NN are_VBP not_RB predicted_VBN to_TO disrupt_VB any_DT transcription_NN ._SENT The_DT plasmids_NNS used_VBN and_CC the_DT strategy_NN for_IN introducing_VBG part_NN of_IN the_DT epo_NN genes_NNS in_IN M._NP xanthus_NNS are_VBP diagramed_VBN in_IN Fig._NN and_CC ._SENT First_RB ,_, plasmid_NP pKOS35-154_NP was_VBD constructed_VBN ._SENT This_DT plasmid_NN contains_VBZ a_DT 7-kb_JJ fragment_NN of_IN M._NP xanthus_NP DNA_NP ,_, 2.8_CD kb_NN of_IN the_DT dev_NP operon_NN and_CC 4.2_CD kb_NN downstream_JJ of_IN dev_NP ,_, and_CC two_CD regions_NNS from_IN the_DT epo_NN gene_NN cluster_NN :_: a_DT region_NN from_IN module_NN 7_CD and_CC a_DT region_NN 4.7_CD kb_NN downstream_JJ of_IN epoK_NN ._SENT Between_IN the_DT two_CD epo_NN fragments_NNS is_VBZ the_DT kanamycin_NN resistance_NN gene_NN from_IN Tn5_NP and_CC the_DT E._NP coli_NNS galK_NN gene_NN ._SENT Plasmid_NP pKOS35-154_NP was_VBD linearized_VBN and_CC electroporated_VBN into_IN M._NP xanthus_NN to_TO produce_VB strain_NN K35-159_NP ._SENT Kanamycin-resistant_NP colonies_NNS arise_VBP from_IN a_DT double_JJ recombination_NN event_NN :_: one_CD recombination_NN with_IN the_DT dev_NP locus_NN and_CC another_DT with_IN the_DT region_NN 3_CD '_'' to_TO dev_NP ._SENT This_DT introduces_VBZ regions_NNS from_IN the_DT epo_NN gene_NN cluster_NN that_WDT serve_VBP as_IN recombination_NN sites_NNS for_IN a_DT cosmid_NN containing_VBG the_DT downstream_JJ half_NN of_IN the_DT epo_NN genes_NNS ._SENT Next_RB ,_, the_DT cosmid_JJ pKOS90-23_NN ,_, which_WDT contains_VBZ epoE_NN ,_, epoF_NN ,_, epoK_NNS ,_, and_CC downstream_JJ DNA_NN ,_, was_VBD electroporated_VBN into_IN K35-159_NP ._SENT This_DT strain_NN ,_, K35-174.6_NP ,_, results_NNS from_IN a_DT single_JJ recombination_NN event_NN ._SENT To_TO remove_VB the_DT cosmid_JJ vector_NN and_CC leave_VB only_RB the_DT region_NN between_IN the_DT two_CD flanking_VBG epo_NN regions_NNS inserted_VBN by_IN plasmid_NP pKOS35-154_NP ,_, a_DT second_JJ recombination_NN event_NN was_VBD selected_VBN by_IN isolating_VBG galactose-resistant_JJ colonies_NNS ._SENT The_DT E._NP coli_NNS galK_NN gene_NN renders_VBZ M._NP xanthus_NN sensitive_JJ to_TO 1_CD %_NN galactose_NN and_CC provides_VBZ a_DT convenient_JJ method_NN for_IN isolating_JJ bacteria_NNS that_WDT have_VBP lost_VBN the_DT galK_NN gene_NN ,_, which_WDT occurs_VBZ by_IN a_DT second_JJ recombination_NN event_NN between_IN the_DT flanking_VBG epo_NN region_NN and_CC its_PP$ homologous_JJ DNA_NN on_IN the_DT cosmid_NN ._SENT This_DT results_NNS in_IN strain_NN K35-175_NP ,_, which_WDT contains_VBZ part_NN of_IN epoE_NN ,_, the_DT complete_JJ epoF_NN and_CC epoK_NN genes_NNS ,_, and_CC 4.7_CD kb_NN of_IN DNA_NN downstream_RB ._SENT The_DT 4.7_CD kb_NN of_IN DNA_NN downstream_JJ of_IN epoK_NN contains_VBZ several_JJ putative_JJ open_JJ reading_NN frames_NNS (_( arrows_NNS in_IN Fig._NN )_) ._SENT None_NN of_IN the_DT open_JJ reading_NN frames_NNS contain_VBP homologies_NNS to_TO proteins_NNS which_WDT would_MD suggest_VB a_DT function_NN ._SENT However_RB ,_, the_DT first_JJ and_CC last_JJ open_JJ reading_NN frames_NNS encode_VBP proteins_NNS predicted_VBD to_TO harbor_VB membrane_NN spanning_VBG regions_NNS and_CC so_RB may_MD code_VB for_IN transporter_NN proteins_NNS ._SENT To_TO insert_VB epoA_NN ,_, epoB_NN ,_, epoC_NN ,_, epoD_NN ,_, and_CC the_DT remaining_VBG region_NN of_IN epoE_NN ,_, a_DT second_JJ round_NN of_IN recombination_NN ,_, similar_JJ to_TO the_DT first_JJ ,_, was_VBD performed_VBN ._SENT Plasmid_NP pKOS90-22_NN was_VBD linearized_VBN and_CC electroporated_VBN into_IN K35-175_NP to_TO construct_VB K111-13.2_NP ._SENT Next_JJ ,_, cosmid_JJ pKOS90-38_NN was_VBD electroporated_VBN into_IN K111-13.2_NP to_TO construct_VB K111-13.22_NP ._SENT Finally_RB ,_, to_TO complete_VB the_DT construction_NN of_IN the_DT gene_NN cluster_NN ,_, a_DT galactose-resistant_JJ version_NN of_IN K111-13.22_NP was_VBD selected_VBN ._SENT This_DT final_JJ recombinant_JJ strain_NN contains_VBZ the_DT epothilone_JJ gene_NN cluster_NN plus_CC 4.7_CD kb_NN upstream_RB of_IN the_DT translational_JJ start_NN of_IN epoA_NN and_CC 4.7_CD kb_NN downstream_JJ of_IN the_DT translational_JJ stop_NN of_IN epoK_NN ._SENT Eighteen_CD isolates_NNS were_VBD examined_VBN for_IN epothilone_JJ production_NN and_CC analyzed_VBD by_IN Southern_NP blotting_VBG ._SENT From_IN this_DT ,_, the_DT two_CD isolates_NNS that_WDT produced_VBD the_DT highest_JJS amounts_NNS of_IN epothilones_NNS were_VBD further_RBR examined_VBN and_CC are_VBP referred_VBN to_TO as_IN K111-32_NP isolates_VBZ 1_CD and_CC 2_CD ._SENT Although_IN the_DT epothilones_NNS are_VBP secreted_VBN into_IN the_DT medium_NN when_WRB produced_VBN in_IN S._NP cellulosum_NN ,_, we_PP were_VBD not_RB certain_JJ whether_IN a_DT specific_JJ transporter_NN was_VBD needed_VBN to_TO transport_VB the_DT epothilones_NNS out_RP of_IN the_DT cell_NN ._SENT In_IN constructing_VBG the_DT M._NP xanthus_NN epothilone_NN producer_NN ,_, two_CD open_JJ reading_NN frames_NNS that_WDT appear_VBP to_TO encode_VB membrane-spanning_NN proteins_NNS were_VBD contained_VBN within_IN the_DT 65.4_CD kb_NN of_IN DNA_NP ._SENT The_DT two_CD isolates_NNS of_IN K111-32_NP were_VBD grown_VBN in_IN CMM_NP medium_NN for_IN 60_CD to_TO 72_CD h_NN ,_, the_DT period_NN of_IN maximum_JJ epothilone_NN accumulation_NN (_( data_NNS not_RB shown_VBN )_) ,_, and_CC the_DT levels_NNS of_IN epothilone_NN were_VBD analyzed_VBN in_IN the_DT total_JJ culture_NN ,_, which_WDT contains_VBZ the_DT cells_NNS and_CC medium_NN together_RB ;_: in_IN the_DT medium_NN ;_: and_CC in_IN the_DT cells_NNS alone_RB ._SENT The_DT results_NNS show_VBP that_IN the_DT epothilones_NNS are_VBP secreted_VBN into_IN the_DT medium_NN and_CC only_JJ trace_NN amounts_NNS are_VBP retained_VBN in_IN the_DT cells_NNS ._SENT We_PP currently_RB do_VBP not_RB know_VB if_IN the_DT two_CD open_JJ reading_NN frames_NNS ,_, predicted_VBD to_TO encode_VB membrane-spanning_NN proteins_NNS ,_, are_VBP required_VBN for_IN the_DT export_NN of_IN the_DT epothilones_NNS ._SENT Comparison_NN of_IN the_DT epothilones_NNS produced_VBN in_IN M._NP xanthus_NN versus_IN those_DT produced_VBN in_IN S._NP cellulosum_NN shows_VBZ that_IN the_DT levels_NNS of_IN epothilone_JJ B_NN are_VBP about_RB 100-fold_JJ lower_JJR in_IN M._NP xanthus_NN under_IN the_DT growth_NN conditions_NNS tested_VBD ._SENT Interestingly_RB ,_, the_DT ratio_NN of_IN epothilone_JJ A_NP to_TO epothilone_NP B_NP produced_VBD in_IN M._NP xanthus_NN is_VBZ approximately_RB 1:10_CD ,_, in_IN stark_JJ contrast_NN to_TO S._NP cellulosum_NN ,_, where_WRB the_DT ratio_NN of_IN epothilone_JJ A_NP to_TO epothilone_NP B_NP is_VBZ roughly_RB 2:1_CD ._SENT The_DT difference_NN between_IN epothilone_NP A_NP and_CC epothilone_NP B_NP is_VBZ the_DT presence_NN of_IN a_DT methyl_NN group_NN at_IN carbon_NN 12_CD ._SENT This_DT methyl_NN group_NN is_VBZ derived_VBN from_IN methylmalonyl-CoA_NN and_CC not_RB by_IN C_NP methylation_NN ,_, which_WDT indicates_VBZ that_IN the_DT acyltransferase_NN from_IN module_NN 4_CD is_VBZ able_JJ to_TO accept_VB either_DT malonyl-CoA_NN or_CC methylmalonyl-CoA_NN ._SENT Thus_RB ,_, in_IN M._NP xanthus_NN ,_, there_EX may_MD be_VB a_DT larger_JJR pool_NN of_IN methylmalonyl-CoA_NN during_IN epothilone_NN production_NN that_WDT increases_VBZ the_DT production_NN of_IN epothilone_JJ B_NN over_IN epothilone_JJ A._NP Construction_NN of_IN an_DT epoK_NN mutant_NN ._SENT |_SYM Epothilone_NP A_NP and_CC epothilone_NP B_NP are_VBP the_DT major_JJ constituents_NNS of_IN the_DT fermentation_NN of_IN the_DT natural_JJ and_CC heterologous_JJ hosts_NNS ._SENT However_RB ,_, epothilone_NP D_NP appears_VBZ to_TO have_VB the_DT best_RBS therapeutic_JJ index_NN (_( -_: ,_, )_) ._SENT Of_IN the_DT two_CD other_JJ candidate_NN drugs_NNS currently_RB in_IN clinical_JJ trials_NNS ,_, epothilone_JJ B_NP and_CC aza-epothilone_NP B_NP ,_, epothilone_NP D_NP proved_VBD superior_JJ in_IN reducing_VBG tumor_NN size_NN in_IN nude_JJ mice_NNS containing_VBG MX-1_JJ tumor_NN cells_NNS ._SENT Epothilone_NP B_NP is_VBZ synthesized_VBN from_IN epothilone_JJ D_NN by_IN the_DT formation_NN of_IN the_DT epoxide_NN at_IN C-12-C-13_NP ,_, which_WDT is_VBZ added_VBN by_IN EpoK_NP ,_, a_DT cytochrome_NN P450_NN ._SENT This_DT has_VBZ been_VBN demonstrated_VBN in_IN vitro_NN by_IN the_DT conversion_NN of_IN epothilone_JJ D_NN to_TO epothilone_JJ B_NN in_IN the_DT presence_NN of_IN purified_VBN EpoK_NP ._SENT Thus_RB ,_, a_DT strain_NN that_WDT contains_VBZ an_DT epoK_NN mutation_NN would_MD be_VB a_DT valuable_JJ strain_NN for_IN production_NN of_IN epothilone_JJ D._NP Two_NP strains_NNS that_WDT contain_VBP mutations_NNS in_IN epoK_NNS were_VBD constructed_VBN ._SENT One_PP contains_VBZ an_DT insertion_NN of_IN the_DT kanamycin_NN gene_NN from_IN Tn5_NP ,_, and_CC the_DT other_JJ has_VBZ an_DT in-frame_JJ deletion_NN of_IN epoK_NN that_WDT removes_VBZ 705_CD bp_NN ,_, or_CC 56_CD %_NN of_IN the_DT gene_NN ._SENT Although_IN there_EX are_VBP no_DT genes_NNS downstream_JJ of_IN epoK_NNS that_WDT are_VBP necessary_JJ for_IN the_DT synthesis_NN of_IN epothilones_NNS ,_, there_EX may_MD be_VB genes_NNS important_JJ for_IN export_NN ,_, particularly_RB the_DT first_JJ open_JJ reading_NN frame_NN downstream_JJ of_IN epoK_NN that_WDT is_VBZ predicted_VBN to_TO contain_VB several_JJ transmembrane_NN spanning_VBG regions_NNS ._SENT Therefore_RB ,_, it_PP was_VBD important_JJ to_TO construct_VB mutations_NNS that_WDT will_MD not_RB have_VB polar_JJ effects_NNS ._SENT With_IN the_DT insertion_NN ,_, the_DT kanamycin_NN resistance_NN gene_NN is_VBZ oriented_VBN such_JJ that_IN its_PP$ promoter_NN would_MD drive_VB expression_NN of_IN genes_NNS downstream_JJ of_IN epoK_NN ._SENT Strains_NNS harboring_VBG mutations_NNS in_IN epoK_NNS were_VBD grown_VBN ,_, and_CC the_DT amount_NN of_IN epothilones_NNS produced_VBN are_VBP presented_VBN in_IN Fig._NN A._NP Isolates_NP of_IN K111-40_NP contain_VBP the_DT insertion_NN of_IN the_DT kanamycin_NN resistance_NN gene_NN (_( epoK::npt_NNS )_) ,_, whereas_IN the_DT isolates_NNS of_IN K111-72_NP contain_VBP an_DT in-frame_JJ deletion_NN (_( DeltaepoK_NP )_) ._SENT The_DT data_NNS reveal_VBP that_IN the_DT levels_NNS of_IN epothilone_NN A_DT from_IN the_DT isolates_NNS of_IN K111-32_NP are_VBP similar_JJ to_TO the_DT levels_NNS of_IN epothilone_JJ C_NP from_IN the_DT strains_NNS carrying_VBG a_DT mutation_NN in_IN epoK_NN and_CC that_IN both_DT types_NNS of_IN mutations_NNS ,_, the_DT insertion_NN and_CC the_DT in-frame_JJ deletion_NN ,_, result_NN in_IN the_DT same_JJ levels_NNS of_IN production_NN ._SENT Interestingly_RB ,_, the_DT levels_NNS of_IN epothilone_NN D_NN produced_VBN are_VBP about_RB fivefold_RB lower_JJR than_IN the_DT epoK_NN mutant_JJ strains_NNS relative_JJ to_TO epothilone_JJ B_NN produced_VBN from_IN K111-32_NP ._SENT Because_IN the_DT resin_NN XAD-16_NN is_VBZ used_VBN in_IN the_DT fermentation_NN of_IN the_DT S._NP cellulosum_NN strain_NN that_WDT produces_VBZ epothilone_NN ,_, we_PP investigated_VBD whether_IN binding_VBG of_IN the_DT epothilones_NNS to_TO the_DT resin_NN XAD-16_NN would_MD sequester_VB them_PP from_IN the_DT cells_NNS and_CC stabilize_VB the_DT compounds_NNS ,_, particularly_RB epothilone_JJ D._NP Figure_NP shows_VBZ the_DT results_NNS of_IN fermentations_NNS in_IN the_DT presence_NN XAD-16_NN ._SENT The_DT levels_NNS of_IN epothilone_NP D_NP produced_VBD from_IN the_DT strains_NNS harboring_VBG the_DT epoK_NN mutation_NN are_VBP higher_JJR in_IN the_DT presence_NN of_IN XAD_NP and_CC are_VBP equivalent_JJ to_TO epothilone_JJ B_NP levels_NNS produced_VBN in_IN K111-32_NP ._SENT These_DT results_NNS suggest_VBP that_IN epothilone_NP D_NP is_VBZ unstable_JJ during_IN the_DT fermentation_NN process_NN relative_JJ to_TO the_DT other_JJ epothilones_NNS ._SENT Interestingly_RB ,_, the_DT strain_NN K111-32_NP produced_VBD equal_JJ amounts_NNS of_IN epothilone_JJ B_NP and_CC epothilone_NP D_NP in_IN the_DT presence_NN of_IN XAD-16_NP ,_, even_RB though_IN it_PP contains_VBZ a_DT fully_RB functional_JJ epoK_NN ._SENT This_DT is_VBZ not_RB seen_VBN in_IN epothilone_JJ production_NN from_IN S._NP cellulosum_NN ._SENT In_IN the_DT presence_NN of_IN XAD-16_NP ,_, epothilone_NP C_NP and_CC epothilone_NP D_NP make_VB up_RP less_JJR than_IN 10_CD %_NN of_IN the_DT total_JJ amount_NN of_IN epothilones_NNS produced_VBN in_IN shake_NN flask_NN experiments_NNS (_( B._NP Julien_NP ,_, unpublished_JJ data_NNS )_) ._SENT This_DT suggests_VBZ that_IN in_IN S._NP cellulosum_NN ,_, the_DT majority_NN of_IN the_DT epothilone_NN D_NN is_VBZ converted_VBN to_TO epothilone_JJ B_NN before_IN release_NN into_IN the_DT medium_NN ,_, whereas_IN in_IN M._NP xanthus_NP ,_, epothilone_NP D_NP has_VBZ an_DT equal_JJ probability_NN of_IN being_VBG released_VBN into_IN the_DT medium_NN as_IN being_VBG acted_VBN upon_RP by_IN EpoK_NP ._SENT FIG._NN 2_CD ._SENT |_SYM Plasmids_NNS used_VBN for_IN introduction_NN of_IN recombination_NN sites_NNS for_IN epothilone_JJ genes_NNS ._SENT Plasmids_NNS used_VBN for_IN introduction_NN of_IN recombination_NN sites_NNS for_IN epothilone_JJ genes_NNS ._SENT Lightly_RB shaded_JJ boxes_NNS represent_VBP regions_NNS of_IN DNA_NP from_IN M._NP xanthus_NN ._SENT Dark_JJ boxes_NNS represent_VBP selectable_JJ markers_NNS or_CC regions_NNS of_IN DNA_NN from_IN the_DT epothilone_JJ gene_NN cluster_NN ._SENT Arrows_NNS represent_VBP the_DT direction_NN of_IN transcription_NN ._SENT FIG._NN 3_CD ._SENT |_SYM Schematic_NP for_IN introduction_NN of_IN a_DT portion_NN of_IN the_DT epothilone_JJ genes_NNS into_IN the_DT chromosome_NN of_IN M._NP xanthus_NP Schematic_NP for_IN introduction_NN of_IN a_DT portion_NN of_IN the_DT epothilone_JJ genes_NNS into_IN the_DT chromosome_NN of_IN M._NP xanthus_NP ._SENT (_( A_NP )_) The_DT introduction_NN of_IN recombination_NN sites_NNS for_IN the_DT epothilone_JJ genes_NNS from_IN pKOS35-154_NN ._SENT Arrows_NNS indicate_VBP direction_NN of_IN transcription_NN ._SENT Boxes_NNS with_IN curved_VBN ends_NNS represent_VBP partial_JJ genes_NNS or_CC fragments_NNS of_IN DNA_NP from_IN S._NP cellulosum_NN ._SENT (_( B_NP )_) Introduction_NN of_IN the_DT cosmid_JJ pKOS90-23_NN into_IN the_DT chromosome_NN ._SENT (_( C_LS )_) Resulting_JJ genetic_JJ structure_NN after_IN selecting_VBG for_IN the_DT second_JJ recombination_NN event_NN to_TO remove_VB duplicated_VBN regions_NNS and_CC regions_NNS with_IN the_DT kanamycin_NN resistance_NN and_CC galK_NN genes_NNS ._SENT Arrows_NNS indicate_VBP putative_JJ open_JJ reading_NN frames_NNS and_CC their_PP$ direction_NN of_IN transcription_NN in_IN the_DT 4.5_CD kb_NN of_IN S._NP cellulosum_NN DNA_NN downstream_JJ of_IN epoK_NN ._SENT FIG._NN 4_CD ._SENT |_SYM Production_NN levels_NNS from_IN various_JJ strains_NNS in_IN the_DT absence_NN (_( A_NP )_) or_CC presence_NN (_( B_NP )_) of_IN XAD-16_NP ._SENT Production_NN levels_NNS from_IN various_JJ strains_NNS in_IN the_DT absence_NN (_( A_NP )_) or_CC presence_NN (_( B_NP )_) of_IN XAD-16_NP ._SENT TABLE_NN 1_CD |_SYM Epothilone_JJ production_NN in_IN K111-32_NP Myxobacteria_NP produce_VB a_DT variety_NN of_IN novel_JJ polyketides_NNS with_IN novel_JJ modes_NNS of_IN action_NN ,_, including_VBG the_DT epothilones_NNS ._SENT Current_JJ understanding_NN of_IN polyketide_NN synthase_NN genes_NNS allows_VBZ them_PP to_TO be_VB engineered_VBN to_TO produce_VB novel_NN compounds_NNS that_WDT may_MD have_VB superior_JJ activity_NN relative_JJ to_TO the_DT natural_JJ ones_NNS ._SENT However_RB ,_, engineering_NN of_IN genes_NNS in_IN strains_NNS of_IN S._NP cellulosum_NN ,_, as_RB well_RB as_IN in_IN most_JJS other_JJ myxobacteria_NNS ,_, would_MD be_VB extremely_RB difficult_JJ ,_, due_JJ to_TO the_DT lack_NN of_IN genetics_NNS and_CC molecular_JJ techniques_NNS available_JJ ._SENT Although_IN Streptomyces_NP expression_NN systems_NNS have_VBP been_VBN developed_VBN for_IN production_NN of_IN polyketides_NNS ,_, the_DT yields_NNS can_MD be_VB low_JJ ,_, and_CC unforeseen_JJ side_NN effects_NNS of_IN heterologously_RB producing_VBG a_DT non-actinomycetes_NN compound_NN ,_, particularly_RB from_IN a_DT gram-negative_JJ bacterium_NN ,_, can_MD be_VB problematic_JJ ,_, as_RB seen_VBN with_IN the_DT epothilones_NNS (_( Tang_NP et_FW al._FW ,_, unpublished_JJ data_NNS )_) ._SENT Thus_RB ,_, the_DT work_NN presented_VBD here_RB demonstrates_VBZ that_IN M._NP xanthus_NP provides_VBZ an_DT important_JJ alternative_JJ host_NN for_IN production_NN of_IN polyketides_NNS ,_, especially_RB those_DT from_IN other_JJ myxobacteria_NNS ._SENT Although_IN the_DT levels_NNS of_IN epothilones_NNS reported_VBD here_RB are_VBP low_JJ ,_, through_IN medium_JJ development_NN and_CC using_VBG a_DT feeding_VBG strategy_NN of_IN Casitone_NP and_CC methyl_NN oleate_NN ,_, current_JJ levels_NNS of_IN epothilone_JJ B_NN are_VBP higher_JJR than_IN those_DT obtained_VBN with_IN the_DT epothilone-producing_JJ S._NP cellulosum_NN strain_NN So_IN ce90_NN ._SENT Furthermore_RB ,_, mutants_NNS that_WDT harbor_VBP a_DT mutation_NN in_IN epoK_NNS produce_VBP 50_CD to_TO 100_CD times_NNS more_RBR epothilone_JJ D_NN than_IN does_VBZ So_RB ce90_JJ ._SENT From_IN the_DT work_NN presented_VBD here_RB ,_, important_JJ information_NN was_VBD obtained_VBN as_RB to_TO the_DT use_NN of_IN M._NP xanthus_NN as_IN a_DT heterologous_JJ host_NN ._SENT First_RB ,_, the_DT strain_NN used_VBD has_VBZ a_DT P-pant_JJ transferase_NN that_WDT is_VBZ able_JJ to_TO modify_VB both_DT ACP_NN and_CC PCP_NP domains_NNS ._SENT Second_RB ,_, the_DT strain_NN has_VBZ a_DT pool_NN of_IN methylmalonyl-CoA_NN during_IN the_DT time_NN of_IN epothilone_NN synthesis_NN ._SENT Furthermore_RB ,_, during_IN this_DT time_NN period_NN ,_, there_EX may_MD be_VB more_JJR methylmalonyl-CoA_NN than_IN malonyl-CoA_NN ,_, as_RB evidenced_VBN by_IN the_DT ratios_NNS of_IN epothilone_JJ A_NP and_CC epothilone_NP B_NP produced_VBD ,_, which_WDT is_VBZ approximately_RB 1:10_CD ._SENT Finally_RB ,_, the_DT promoter_NN that_WDT drives_VBZ expression_NN of_IN the_DT epothilone_JJ genes_NNS in_IN S._NP cellulosum_NN most_RBS likely_JJ is_VBZ the_DT same_JJ one_CD that_WDT is_VBZ utilized_VBN in_IN M._NP xanthus_NN ._SENT Since_IN no_DT specific_JJ regulator_NN proteins_NNS have_VBP been_VBN found_VBN associated_VBN with_IN any_DT of_IN the_DT several_JJ polyketide_NN synthase_NN genes_NNS sequenced_JJ from_IN S._NP cellulosum_NP or_CC Stigmatella_NP aurantiaca_NP (_( ,_, ,_, -_: )_) ,_, there_EX is_VBZ likely_RB some_DT global_JJ regulator_NN that_WDT activates_VBZ production_NN of_IN secondary_JJ metabolites_NNS at_IN the_DT onset_NN of_IN stationary_JJ phase_NN ,_, and_CC this_DT regulation_NN is_VBZ similar_JJ in_IN many_JJ myxobacteria_NNS ._SENT Further_JJR support_NN is_VBZ provided_VBN by_IN the_DT fact_NN that_IN the_DT myxothiazole_NN promoter_NN from_IN S._NP aurantiaca_NP can_MD drive_VB expression_NN of_IN the_DT epothilone_JJ genes_NNS in_IN M._NP xanthus_NP (_( S._NP Shah_NP and_CC B._NP Julien_NP ,_, unpublished_JJ data_NNS )_) ._SENT Now_RB that_DT epothilone_NN can_MD be_VB produced_VBN in_IN a_DT heterologous_JJ host_NN tolerant_JJ of_IN its_PP$ production_NN and_CC amenable_JJ to_TO genetic_JJ manipulation_NN ,_, the_DT stage_NN is_VBZ set_VBN to_TO make_VB new_JJ compounds_NNS that_WDT can_MD only_RB be_VB made_VBN by_IN engineering_NN of_IN the_DT genes_NNS and_CC to_TO identify_VB those_DT with_IN increased_VBN therapeutic_JJ value_NN ._SENT 